Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00074776 · ClinicalTrials.gov registry record · Phase 3
Acute Treatment of Bipolar II Depression
A Phase 3 study of Bipolar Disorder, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT00074776: Completed Phase 3 study of Bipolar Disorder, sponsored by Stanford University.
NCT00074776 is a Phase 3 study of Bipolar Disorder that has completed, run by Stanford University. The registered enrollment target is 102 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00074776, a Phase 3 study of Bipolar Disorder, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the medications lithium and lamotrigine (Lamictal®) in treating depression in individuals with bipolar II disorder.
Conditions Studied
Interventions
- DRUG Lamotrigine
- DRUG Lithium
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2003-05 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
What the finished NCT00074776 record still lists
NCT00074776 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Lamotrigine is the first listed.
NCT00074776 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00074776 about?
NCT00074776 is a clinical study titled "Acute Treatment of Bipolar II Depression". This study will compare the medications lithium and lamotrigine (Lamictal®) in treating depression in individuals with bipolar II disorder.
What is the current status of trial NCT00074776?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 102 participants. The study started on 2003-05. Estimated completion is 2007-10.
What conditions does trial NCT00074776 study?
This clinical trial studies the following conditions: Bipolar Disorder.
What interventions are being tested in trial NCT00074776?
The interventions under investigation include: Lamotrigine (DRUG), Lithium (DRUG).
Who is sponsoring clinical trial NCT00074776?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00074776 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00074776's enrollment target sits among peer trials
102 66th of 162 higher than 96 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
RECRUITING · Phase 3
-
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RECRUITING · Phase 3
-
Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
COMPLETED · Phase 3
-
Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression
COMPLETED · Phase 3
-
Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia